TNYA

Conviction 4HealthcareScan · Mon, Aug 10, 2026

TNYA$0.7406+1.90%

ResistanceSupportVol 14Insider sell

Vol MA14 1.82M

May 11May 28Jun 16Jul 6Jul 23Aug 10

Tenaya Therapeutics, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.tenayatherapeutics.com ↗

Price0.7406

Change+1.90%

Gap+0.45%

Rel volume0.72×

Avg volume1.81M

Avg $ vol1.41M

SMA 200.7771

SMA 500.7707

SMA 2000.8687

Price vs 50-3.91%

Price vs 200-14.75%

MA stackbearish

50/200 cross—

Supertrendup · 0.7093

RSI (14)45

MACD hist-0.01

MACD cross—

Stoch %K / %D19 / 10

ADX (14)11

+DI / −DI17 / 16

RSI divergence—

MACD divergence—

ATR %+6.86%

ADR %5.76%

52w high2.10

52w low0.5500

From 52w high-64.73%

Above 52w low+34.65%

New 52w highNo

SqueezeOff

Bollinger width21.80%

%B0.28

Donchian pos14.22%

Donchian high0.8649

Donchian low0.7200

AVWAP (52w high)0.9307

vs AVWAP high-20.42%

AVWAP (52w low)0.8025

vs AVWAP low-7.71%

OBV trendFlat

Chaikin MF (20)-0.05

Today vs 20d0.72×

Avg vol (14d)1.82M

Avg vol (20d)1.81M

Avg $ vol (20d)1.41M

Market cap166.06M

RS 3m (vs SPY)-20.03%

RS 6m (vs SPY)-17.21%

RS line new highNo

Trend template1/8

Technical rank17.7

1 week+1.59%

1 month-14.91%

3 months-25.94%

6 months-8.74%

1 year+11.67%

YTD+0.80%

P/E-1.83

P/B2.39

P/S—

P/FCF-2.41

EPS-0.5900

Div yield—

ROE-130.53%

ROA-96.85%

Debt/Eq—

Current4.52

EV/EBITDA-1.04

Gross margin—

Net margin—

Rev growth—

EPS growth18.48%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value87.98M

Revenue1.11M

Net income-43.39M

Gross profit—

Free cash flow-68.88M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out217M

Employees70

ListedFri, Jul 30, 2021

Free float155.92M

Float %71.9%

Short interest24.92M

Days to cover7.4d

Short volume44.0%

Squeeze score60 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction4 / 100

Pattern quality—

Tech rank17.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.8901

Support0.6850

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in TNYA

All disclosures →

No recent disclosed trades by Congress in TNYA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in TNYA · 7 buys · 3 sells

Insider	Side	Shares	Value	Traded	Filed
Srivastava Deepak Director · Stock Option (Right to buy) · 2026-05-28	Grant	120K	$0	2026-05-28	2026-05-29
Williams R Sanders Director · Stock Option (Right to buy) · 2026-05-28	Grant	120K	$0	2026-05-28	2026-05-29
Burroughs Amy L. Director · Stock Option (Right to buy) · 2026-05-28	Grant	120K	$0	2026-05-28	2026-05-29
Walsh Jeffrey T. Director · Stock Option (Right to buy) · 2026-05-28	Grant	120K	$0	2026-05-28	2026-05-29
Lee June Director · Stock Option (Right to buy) · 2026-05-28	Grant	120K	$0	2026-05-28	2026-05-29
Parschauer Karah Herdman Director · Stock Option (Right to buy) · 2026-05-28	Grant	120K	$0	2026-05-28	2026-05-29
Stehman-Breen Catherine Director · Stock Option (Right to buy) · 2026-05-28	Grant	120K	$0	2026-05-28	2026-05-29
Higa Tomohiro SVP, Finance · Common Stock · 2026-05-18	Sell	1.49K	$1K	2026-05-18	2026-05-19
Tingley Whittemore Chief Medical Officer · Common Stock · 2026-05-18	Sell	3.12K	$2K	2026-05-18	2026-05-19
Ali Faraz Chief Executive Officer · Common Stock · 2026-05-18	Sell	3.39K	$3K	2026-05-18	2026-05-19

SEC filings

EDGAR filings in TNYA · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.